US Patent 11365184 Antiproliferative compounds, and their pharmaceutical compositions and uses
Patent 11365184 was granted and assigned to Celgene on June, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
John Sapienza0
Joshua Hansen0
Matthew D. Alexander0
Matthew D. Correa0
Raj Kumar Raheja0
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113651840
Date of Patent
June 21, 2022
0Patent Application Number
168114140
Date Filed
March 6, 2020
0Patent Citations
Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Edits on 22 Jun, 2022
Golden AI
Edits made to:
Infobox (+20 properties)
Article (+145 characters)
US Patent 11365184 Antiproliferative compounds, and their pharmaceutical compositions and uses
Article
Compounds of formula A-I and B-I, compositions comprising the compounds, methods of making the compounds and methods of their uses are disclosed.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11365184
Date of patent
June 21, 2022
Patent application number
16811414
Date Filed
March 6, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11365184 Antiproliferative compounds, and their pharmaceutical compositions and uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
